Drugs / zamzetoclax
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05006794 | Sep 2021 → Jun 2025 | cancer | Gilead Sciences | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zamzetoclax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05006794 ↗ |
| Modality | Small molecule | — CHEMBL6068037 ↗ |
| Route | Oral | “Tablet(s) administered orally” NCT05006794 ↗ |